Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Decitabine

Catalog No. ABIN1439981
  • Application
    Blocking Antibody (Inhibition)
    Characteristics
    DNA Methyltransferase inhibitor
    Hypermethylating agent
    Inhibits melanoma cancer cell growth
  • Restrictions
    For Research Use only
  • Storage
    4 °C
  • Background
    Cytosine analog, that when incorporated into DNA, acts as a suicide substrate for DNA methyltransferase. Inhibits DNA methyltransferase and results in DNA hypomethylation and activation of silent genes. Chemotherapeutic agent, suppresses growth of human tumor cell lines. Demethylates differentiation-related genes, reverses embryonic stem cell differentiation. Decitabine is an epigenetic modifier that gives rise to DNA demethylation (hypomethylation) and gene activation by remodeling 'opening' chromatin. Genes are synergistically reactivated when demethylation is combined with histone hyperacetylation. This remodeling of chromatin structure allows transcription factors to bind to the promoter regions, assembly of the transcription complex, and gene expression.
    CAS-No
    2353-33-5
You are here:
Support